echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > All localities are vigorously carrying out special rectification actions for drug safety, and the pharmaceutical industry will face stricter supervision

    All localities are vigorously carrying out special rectification actions for drug safety, and the pharmaceutical industry will face stricter supervision

    • Last Update: 2022-04-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In recent years, the state has been promoting the special rectification of drug safety.
    Against this background, all localities have also begun to accelerate the special rectification of drug safety
    .
    Since the beginning of this year, many places have successively started to formulate detailed implementation rules and detailed work requirements based on the actual situation of their administrative regions, and are continuing to further promote the inspection of drug production, operation and use
    .
    Fujian Fujian Province attaches great importance to the special rectification work.
    In addition to researching and formulating the "Fujian Province's Implementation Plan for In-depth Development of Drug Safety Special Rectification Actions", which was issued and implemented on March 21, the special rectification was included in the "Three Mentions of the Drug Administration".
    The key content of the "Three Effects" action to ensure that the rectification action is effective
    .
    The announcement shows that this special rectification will focus on the fields of medicines, medical devices, and cosmetics, with vaccines, blood products, Chinese herbal medicines, Chinese herbal decoction pieces, special drugs, bid-winning varieties, sterile and implantable medical devices, epidemic protection medicines, Children and special cosmetics are the key targets, and the high incidence of counterfeiting is the key area.
    Drug clinical trial institutions, new enterprises, new workshops, expansion of production lines, and commissioned production are used.
    In the past, many problems were found in inspections, and the frequency of unqualified products was supervised and inspected.
    A large number of enterprises are the key targets, comprehensively investigate illegal information from inspection and verification, supervision and sampling, adverse reaction (adverse event) monitoring, network monitoring, public opinion monitoring, complaints and reports and other channels, make full use of big data to carry out analysis and judgment, and carefully screen The clues of major and important cases suspected of violations of laws and regulations will comprehensively improve the pertinence, targeting and effectiveness of special rectification
    .
    Shanghai On February 15, the Shanghai Municipal Food and Drug Administration conveyed the relevant requirements of the State Food and Drug Administration on the in-depth video conference of the drug safety special rectification action through a video conference, and deployed and launched the city's drug safety special rectification action
    .
    At present, a special rectification work leading group has been established, six working groups have been set up, and a special rectification work plan has been formed as soon as possible
    .
    In the next step, the Shanghai Food and Drug Administration will carry out in-depth drug safety special actions across the city, strictly investigate and punish illegal behaviors of drugs, medical devices and cosmetics, comprehensively investigate potential risks, and maintain the safety of citizens' medication
    .
    Jiangsu It is understood that the Jiangsu Provincial Food and Drug Administration regards the special rectification action of drug safety as the key research content of the first meeting of the Provincial Drug Safety Committee since its establishment, and insists on the in-depth development of the special action as a major political task and continues to advance at a high level.

    .
    Since the beginning of this year, drug supervision departments at all levels in Jiangsu Province have intensified drug inspection and law enforcement when carrying out special drug safety rectification actions
    .
    Specifically, in order to promote the formation of the province's "one game of chess" pattern of special drug safety rectification actions, the Jiangsu Provincial Food and Drug Administration has taken multiple measures to strengthen the overall arrangement and supervision of special actions carried out in various regions
    .
    By formulating the "segment and contract" measure, the bureau divided the province's 13 districted cities into four districts, and through the "two joints a week" regular tracking, urged the drug regulatory departments at the city and county levels to implement their territorial regulatory responsibilities
    .
    Since the beginning of this year, the market supervision bureaus of 6 districts and cities including Suzhou and Wuxi have been coordinated to characterize and handle the illegal cases of "two products and one machine"
    .
    Data show that from January to February this year, Jiangsu has investigated and handled 474 administrative penalty cases of "two products and one device", an increase of 76% over the same period last year, effectively ensuring the safety of public medication
    .
    Conclusion Drug safety is a people's livelihood project and a people-friendly project
    .
    Judging from the relevant documents issued by various places and the rectification activities, it will play a further positive role in the standardized development of drug production and sales
    .
    In the future, the industry expects that with more and more special rectification actions for drug safety in provinces and cities, the industry will usher in stricter standards, stricter supervision, stricter penalties, and more serious accountability
    .
    Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
    .
     
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.